Øistein H.
- Country
- Norway
- Department
- Medisinsk poliklinikk, SI Gjøvik
Research Overview
- Phase 3 Randomized Double‑Blind Study Evaluating Efficacy and Safety of JNJ‑78934804 Combination Therapy versus Guselkumab in Moderately to Severely Active Crohn’s Disease
- Phase 3 Randomized Double‑Blind Trial of JNJ‑78934804 Combination Therapy vs Guselkumab in Moderately to Severely Active Ulcerative Colitis
- Efficacy and Safety Evaluation of Oral Zasocitinib in Patients with Moderately to Severely Active Crohn's Disease: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 117 of 245 partner sites.
Specializations
Gastrointestinal Disorders
The investigator specializes in the study and treatment of celiac disease, with particular focus on patients who experience persistent symptoms despite following dietary restrictions.
- Gluten-related disorders
- Refractory celiac disease
- Intestinal mucosal damage
Research activities center on evaluating therapeutic interventions for patients with ongoing celiac disease manifestations.
Clinical Assessment
Expertise in utilizing specialized assessment tools including the Celiac Disease Symptom Diary for monitoring patient outcomes and disease progression.
- Symptom evaluation methods
- Patient-reported outcomes
- Disease monitoring tools
The investigator employs systematic approaches to evaluate therapeutic efficacy in gastrointestinal conditions.
Therapeutic Innovation
Active involvement in investigating novel therapeutic approaches for treatment-resistant celiac disease, particularly in cases where traditional dietary management proves insufficient.
- Novel therapeutic compounds
- Alternative treatment strategies
- Medical interventions beyond diet
Research focuses on developing solutions for patients with persistent symptoms despite dietary compliance.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.